Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Colorcon
Mallinckrodt
AstraZeneca
Merck

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Igi Labs Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for IGI LABS INC, and what generic and branded alternatives to IGI LABS INC drugs are available?

IGI LABS INC has fifty-three approved drugs.

There is one tentative approval on IGI LABS INC drugs.

Summary for Igi Labs Inc
US Patents:0
Tradenames:13
Ingredients:13
NDAs:53

Drugs and US Patents for Igi Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Igi Labs Inc TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063121-001 Oct 31, 1994 DISCN No No   Start Trial   Start Trial
Igi Labs Inc TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063122-001 Oct 31, 1994 DISCN No No   Start Trial   Start Trial
Igi Labs Inc TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063120-001 Oct 31, 1994 DISCN No No   Start Trial   Start Trial
Igi Labs Inc NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 072089-001 Apr 11, 1989 DISCN No No   Start Trial   Start Trial
Igi Labs Inc MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075263-001 Jun 26, 2000 DISCN No No   Start Trial   Start Trial
Igi Labs Inc NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 072093-001 Apr 11, 1989 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Merck
Mallinckrodt
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.